Regeneron Pharmaceuticals, Inc.(NasdaqGS:REGN) dropped from Russell 1000 Dynamic Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,034 USD | +0.99% |
|
-1.60% | +17.75% |
03/07 | Regeneron, Sanofi Say Chronic Obstructive Pulmonary Disease Treatment Gains European Approval | MT |
03/07 | Sanofi obtains EU approval for Dupixent | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.75% | 11TCr | |
+16.61% | 12TCr | |
+17.23% | 2.59TCr | |
-24.11% | 1.93TCr | |
-18.56% | 1.62TCr | |
-18.47% | 1.56TCr | |
-47.75% | 1.46TCr | |
+57.35% | 1.43TCr | |
+5.62% | 1.4TCr | |
+125.88% | 1.13TCr |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Regeneron Pharmaceuticals, Inc.(NasdaqGS: REGN) dropped from Russell 1000 Dynamic Index